Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Journal of Alzheimer'S Disease : JAD
|
August 23, 2021
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
Ester Esteban de Antonio, Alba Pérez-Cordón, Silvia Gil, et al.
Clinical Colorectal Cancer
|
April 13, 2020
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected
Javier Sastre, Virginia de la Orden, Antonio Martínez, et al.
Scientific Reports
|
February 23, 2021
Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Sergi Valero, Marta Marquié, Itziar De Rojas, et al.
Journal of Alzheimer'S Disease : JAD
|
June 16, 2020
Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain
Alba Benaque, Miren Jone Gurruchaga, Carla Abdelnour, et al.
Scientific Reports
|
November 19, 2020
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Sergi Valero, Marta Marquié, Itziar De Rojas, et al.
Scientific Reports
|
October 21, 2020
Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
Alba Pérez-Cordón, Gemma Monté-Rubio, Angela Sanabria, et al.
ESMO Open
|
November 5, 2020
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
Enrique Aranda, Jose Maria Viéitez, Auxiliadora Gómez-España, et al.
Scientific Reports
|
March 20, 2021
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
Natalia Roberto, Maria J Portella, Marta Marquié, et al.
Alzheimer'S Research & Therapy
|
March 19, 2022
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
Montserrat Alegret, Oscar Sotolongo-Grau, Ester Esteban de Antonio, et al.
Oncotarget
|
June 7, 2018
Genome-wide significant risk factors on chromosome 19 and the <i>APOE</i> locus
Sonia Moreno-Grau, Isabel Hernández, Stefanie Heilmann-Heimbach, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Journal of Alzheimer'S Disease : JAD
|
August 23, 2021
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
Ester Esteban de Antonio, Alba Pérez-Cordón, Silvia Gil, et al.
Clinical Colorectal Cancer
|
April 13, 2020
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected
Javier Sastre, Virginia de la Orden, Antonio Martínez, et al.
Scientific Reports
|
February 23, 2021
Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Sergi Valero, Marta Marquié, Itziar De Rojas, et al.
Journal of Alzheimer'S Disease : JAD
|
June 16, 2020
Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain
Alba Benaque, Miren Jone Gurruchaga, Carla Abdelnour, et al.
Scientific Reports
|
November 19, 2020
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
Sergi Valero, Marta Marquié, Itziar De Rojas, et al.
Scientific Reports
|
October 21, 2020
Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
Alba Pérez-Cordón, Gemma Monté-Rubio, Angela Sanabria, et al.
ESMO Open
|
November 5, 2020
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
Enrique Aranda, Jose Maria Viéitez, Auxiliadora Gómez-España, et al.
Scientific Reports
|
March 20, 2021
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
Natalia Roberto, Maria J Portella, Marta Marquié, et al.
Alzheimer'S Research & Therapy
|
March 19, 2022
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
Montserrat Alegret, Oscar Sotolongo-Grau, Ester Esteban de Antonio, et al.
Oncotarget
|
June 7, 2018
Genome-wide significant risk factors on chromosome 19 and the <i>APOE</i> locus
Sonia Moreno-Grau, Isabel Hernández, Stefanie Heilmann-Heimbach, et al.
Page
of 7